Pharmacological interventions for insomnia in the elderly;Pharmakologische behandlung von schlafstörungen bei älteren menschen

Internistische Praxis

Volumn 53, Issue 2, 2013, Pages 377-390

  Schwarz, S ^a   Frolich L ^a   Deuschle, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Elderly; Hypnotic; Pharmacologic management; Sleep disorder; Therapy

Indexed keywords

HYPNOTIC AGENT; MELATONIN;

ACUTE DISEASE; CHRONIC DISEASE; DRUG EFFICACY; DRUG RELEASE; GERIATRIC PATIENT; HUMAN; INSOMNIA; LONG TERM CARE; REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 84876376431     PISSN: 00209570     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Ancoli-Israel S, Cooke JR. Prevalence and comorbidity of insomnia and effect on functioning in elderly populations. J Am Geriatr Soc 2005; 53: S264-271. (Pubitemid 43085985)
2. Ancoli-Israel S. Sleep and its disorders in aging populations. Sleep Med 2009; 10 (Suppl 1): 7-11.
3. Flaherty JH. Insomnia among hospitalized older persons. Clin Geriatr Med 2008; 24: 51-67. (Pubitemid 351491177)
4. Wolkove N, et al. Sleep and aging: 1. Sleep disorders commonly found in older people. CMAJ 2007; 176: 1299-1304. (Pubitemid 46724177)
5. Walker MP, Stickgold R. Sleep-dependent learning and memory consolidation. Neuron 2004; 44: 121-133. (Pubitemid 39348835)
6. Beaulieu-Bonneau S, Hudon C. Sleep disturbances in older adults with mild cognitive impairment. Int Psychogeriatr 2009; 21: 654-666.
7. Liperoti R, Pedone C, Corsonello A. Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD). Curr Neuropharmacol 2008; 6: 117-124. (Pubitemid 352024796)
8. Vaz Fragoso CA, Gill TM. Sleep complaints in community-living older persons: a multifactorial geriatric syndrome. J Am Geriatr Soc 2007; 55: 1853-1866.
9. Bloom HG, et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc 2009; 57: 761-789.
10. Yaffe K, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011; 306: 613-619.
11. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001; 18: 128-147. (Pubitemid 32549908)
12. Richards K, et al. Restless legs syndrome risk factors, behaviors, and diagnoses in persons with early to moderate dementia and sleep disturbance. Behav Sleep Med 2010; 8: 48-61.
13. Mayer G, et al. S3 Leitlinie: Nicht erholsamer Schlaf/ Schlafstörungen. Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM). Somnologie 2009; 13: 4-160.
14. Ebben MR, Spielman AJ. Non-pharmacological treatments for insomnia. J Behav Med 2009; 32: 244-254.
15. Friedman L, et al. Scheduled bright light for treatment of insomnia in older adults. J Am Geriatr Soc 2009; 57: 441-452.
16. Fetveit A. Late-life insomnia: a review. Geriatr Gerontol Int 2009; 9: 220-234.
17. Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol 2006; 25: 3-14. (Pubitemid 43214376)
18. Shub D, Darvishi R, Kunik ME. Non-pharmacologic treatment of insomnia in persons with dementia. Geriatrics 2009; 64: 22-26.
19. Deschenes CL, McCurry SM. Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep 2009; 11: 20-26.
20. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30-39. (Pubitemid 29044264)
21. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007; 62: 1172-1181. (Pubitemid 47599431)
22. Wang PS, et al. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 2001; 49: 1685-1690. (Pubitemid 34007997)
23. Victorri-Vigneau C, et al. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 2007; 64: 198-209. (Pubitemid 47063241)
24. Zammit G. Comparative tolerability of newer agents for insomnia. Drug Saf 2009; 32: 735-748.
25. Dundar Y, et al. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 2004; 19: 305-322. (Pubitemid 39106872)
26. Glass J, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331: 1169.
27. Culberson JW, Ziska M. Prescription drug misuse/abuse in the elderly. Geriatrics 2008; 63: 22-31.
28. Hoffmann F, Scharffetter W, Glaeske G. Verbrauch von Zolpidem und Zopiclon auf Privatrezepten zwischen 1993 und 2007. Nervenarzt 2009; 80: 578-583.
29. Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 2004; 24: 1177-1185. (Pubitemid 39128841)
30. Voyer P, et al. Prevalence of insomnia and its associated factors in elderly long-term care residents. Arch Gerontol Geriatr 2006; 42: 1-20. (Pubitemid 41579094)
31. Dolder C, Nelson M, McKinsey J. Use of non-benzodiazepine hypnotics in the elderly: are all agents the same? CNS Drugs 2007; 21: 389-405. (Pubitemid 46698502)
32. Mayer G, et al. Insomnie. In: Diener HC, Putzki N, Hrsg. Leitlinien der Deutschen Gesellschaft für Neurologie. 4. Aufl. Stuttgart-New York: Thieme; 2008. S. 75-79.
33. Fick DM, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724. (Pubitemid 37517412)
34. Riemann D, et al. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 2002; 35: 165-174.
35. Zavesicka L, et al. Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients. Neuro Endocrinol Lett 2008; 29: 895-901.
36. Hajak G, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001; 62: 453-463. (Pubitemid 32717879)
37. Roth AJ, McCall WV, Liguori A. Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs. J Sleep Res 2011; 20: 552-558.
38. Erman MK. Therapeutic options in the treatment of insomnia. J Clin Psychiatry 2005; 66 (Suppl 9): 18-23. (Pubitemid 43011559)
39. Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 2005; 66: 469-476. (Pubitemid 40593575)
40. Scharf M, et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study. J Clin Psychiatry 2008; 69: 1557-1564.
41. Schneider IS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14: 191-210.
42. Olde Rikkert MG, Rigaud AS. Melatonin in elderly patients with insomnia. A systematic review. Z Gerontol Geriatr 2001; 34: 491-497. (Pubitemid 34087425)
43. Ferguson SA, Rajaratnam SM, Dawson D. Melatonin agonists and insomnia. Expert Rev Neurother 2010; 10: 305-318.
44. Goodridge D, Marr H. Factors associated with falls in an inpatient palliative care unit: an exploratory study. Int J Palliat Nurs 2002; 8: 548-556.
45. Gauillard J, et al. L'hydrate de chloral, un hypnotique a oublier? Encephale 2002; 28: 200-204.
46. Fu PP, et al. Toxicity of kava kava. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008; 26: 89-112. (Pubitemid 351347047)
47. Shelton RC. St John's wort (Hypericum perforatum) in major depression. J Clin Psychiatry 2009; 70 (Suppl 5): 23-27.
48. Taibi DM, et al. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 2007; 11: 209-230. (Pubitemid 46756375)
49. Cooper KL, Relton C. Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev 2010; 14: 329-337.
50. Perlis ML, et al. Placebo effects in primary insomnia. Sleep Med Rev 2005; 9: 381-389. (Pubitemid 41243214)